CANC

Tema Oncology ETF

CANC is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations.


Active, Semi-Diverse

MANAGEMENT MATRIX

IDNA

CLOSEST COMP

FACTOR SCORECARD

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Fund Basics
Fund sponsorDawn Global Topco Ltd.
CategoryGlobal Equities
Asset classEquity
Websitelink...
Inception dateAug 15, 2023
Assets (mns)$19
Expense ratio75 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsMonthly
Taxation1099
Stock selectionProprietary
WeightingProprietary
Holdings TransparencyFull
Derivatives-basedNo
Options availableNo
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings Complete list  + 
REGENERON PHARMACEUTICALS 5.4 %
MERCK & CO. INC. 5.1 %
ILLUMINA INC 3.9 %
DAIICHI SANKYO CO LTD 3.8 %
NOVARTIS AG 3.5 %
CRISPR THERAPEUTICS AG 3.3 %
ASTRAZENECA PLC 3.1 %
ARGENX SE ADR 2.9 %
CHUGAI PHARMACEUTICAL CO LTD 2.9 %
GILEAD SCIENCES INC 2.8 %
Constituent Breakdown
Number of holdings43
Herfindahl-Hirschman Index 270
Wgt avg mkt cap (mns)$54,003
Large cap (>$10bn)53.4%
Mid cap ($2-10bn)27.2%
Small cap (<$2bn)19.5%
Developed mkts.100.0%
Emerging mkts.0.0%
Country Exposure
UNITED STATES 63.0 %
SWITZERLAND 6.9 %
JAPAN 6.7 %
NETHERLANDS 4.6 %
BRITAIN 4.6 %
GERMANY 2.8 %
CHINA 1.9 %
DENMARK 1.8 %
Historical Performance


Standardized Annual Returns (as of 01/31/2024)
YTD1 YR2 YR3 YR5 YR10 YRIncep.
-0.9% -- -- -- -- -- 14.0%
Market Correlations
versus...BetaR-squared
S&P 5000.000%
MSCI EAFE0.000%
MSCI Emg Mkts0.000%
Liquidity Measures
Avg. volume (000)1
Turnover0.2%
Avg. Bid/Ask (% of price)0.34%
ADV of underlying (mns)$6,573
Technical Indicators
Recent close$27.93
30d moving avg.$23.63
Annualized volatility0.0%
Relative strength (RSI)66
Short interest (ETF)0.2%
Short interest (underlying)0.0%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Risk and Returns: CANC vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2019 2020 2021 2022 2023 2024E 2025E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2023 2024E Fwd Est 2025E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
5.9 -35.9 5.6 0.8% --
Based on closing prices from 2/22/2024
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
CANC



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

CANC

-4.0%

Cat. Avg

3.7%

Fund Category: Global Equities

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™-4.0%
Recommendation

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.

Category Overview
There are 345 funds in the Global Equities category, with an average ALTAR Score™ of 3.7% and a standard deviation of 4.8%. CANC's ALTAR Score™ is approximately 1.6 standard deviations below the category average. This places CANC in the 5th percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Composite
CANC
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends


Breakdown

 

Market Activity
Latest price
Change
Volume
Bid/Ask Spread
Update
Today's Trading

Trading data provided for free by IEX. By accessing this data you agree to abide by their Terms of Service.


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
CANC 75.0 34.1 109.1
Peer Avg. -- -- --
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .
Fundamental data for individual fund constituents sourced from FactSet Research Systems.